Monrovia, CA-STAAR Surgical Co. has added senior executives to both its sales team and regulatory/quality assurance teams.
Stealth BioTherapeutics announces data from Phase 2 study of geographic atrophy candidate
Ocuphire announces positive topline results from LYNX-1 Phase 3 trial
Kala reaches deal to sell Eysuvis, Inveltys to Alcon